These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7032927)

  • 1. Adjuvant intermittent chemo-immunotherapy of breast cancer. A prospective study.
    Schreml W; Betzler M; Lang M; Lohrman HP; Kubitza P; Schlag P; Flad HD; Herfarth C; Heimpel H
    Eur J Cancer (1965); 1980; Suppl 1():165-8. PubMed ID: 7032927
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
    Hubay CA; Pearson OH; Marshall JS; Rhodes RS; Debanne SM; Mansour EG; Hermann RE; Jones JC; Flynn WJ; Eckert C; McGuire WL
    Eur J Cancer (1965); 1980; Suppl 1():189-95. PubMed ID: 7032932
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer.
    Klefström P
    Cancer Treat Rep; 1980 Jan; 64(1):65-72. PubMed ID: 6991105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative and functional response of a lymphatic subpopulation during adjuvant intermittent chemo-immunotherapy in breast cancer].
    Betzler M; Flad HD; Huget R; Schreml W; Schlag P; Herfarth C
    Chir Forum Exp Klin Forsch; 1978; (1978):227-30. PubMed ID: 313321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemo-immunotherapy with levamisole in metastatic breast carcinoma: a controlled clinical trial.
    Paterson AH; Edwards AM; Nutting M; Schinnour D; Takats L; McClelland A
    Cancer Clin Trials; 1980; 3(1):5-10. PubMed ID: 6993035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant intermittent chemoimmunotherapy for primary breast cancer: a prospective study with immunologic follow-up.
    Betzler M; Schreml W; Lang M; Lohrmann HP; Flad HD; Schlag P; Herfarth C; Heimpel H
    Recent Results Cancer Res; 1982; 80():185-91. PubMed ID: 7036282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Supportive therapy with xenogenous peptides in patients with metastatic breast cancer undergoing aggressive chemotherapy (modified AC-protocol): a prospective, randomized double-blind study].
    Lange OF
    Onkologie; 1987 Jun; 10(3 Suppl):40-3. PubMed ID: 3309762
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunotherapy with decaris in the early stages of breast cancer].
    Polevaia EB; Derevnina NA; Trubchaninova LP; Veskova TK
    Vopr Onkol; 1988; 34(10):1182-8. PubMed ID: 3055672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy with four drugs for stage 2 breast cancer.
    Wheeler TK; Edelstyn GA; Bates TS; Brinkley D; Evans RG; Kitchen G; MacRae KD; Nicol NT; Spittle M; Wheeler TK
    Eur J Cancer (1965); 1980; Suppl 1():161-3. PubMed ID: 7032926
    [No Abstract]   [Full Text] [Related]  

  • 10. Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.
    Jungi WF; Senn HJ; Amgwerd R; Hochuli E
    Eur J Cancer (1965); 1980; Suppl 1():169-72. PubMed ID: 7032928
    [No Abstract]   [Full Text] [Related]  

  • 11. Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of Milan.
    Rossi A; Bonadonna G; Tancini G; Bajetta E; Marchini S; Valagussa P; Veronesi U
    Eur J Cancer (1965); 1980; Suppl 1():149-56. PubMed ID: 7032924
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgical adjuvant trials in the United States.
    Rozencweig M; Von Hoff DD; Allegra JC; Muggia FM
    Eur J Cancer (1965); 1980; Suppl 1():173-7. PubMed ID: 7032929
    [No Abstract]   [Full Text] [Related]  

  • 13. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunotherapy of cancer using levamisole, immunologic control of the post-surgical patient and graphic follow-up].
    de Carli HO; Llargues JM
    Rev Esp Oncol; 1980; 27(1):67-80. PubMed ID: 7209109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with adriamycin, cyclophosphamide and vicristine for advanced breast cancer supplemented with non cross-resistant combination.
    Jain SP; Pandey UC; Tandon US; Jain KK; Agarwal S
    Indian J Cancer; 1979; 16(3-4):43-6. PubMed ID: 540959
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant chemotherapy with chlorambucil and 5-fluorouracil in primary breast cancer (Cooperative Study Heidelberg).
    Kaufmann M; Fournier DV; Sievers H; Staib I; Wöllgens P; Nedden R; Lochbühler H; Queisser W; Christmann D; Bühner R; Pfuhl PJ; Henningsen B; Kuttig H; Wysocki S; Thüre D; Köhler C; Drings P
    Eur J Cancer (1965); 1980; Suppl 1():157-60. PubMed ID: 7032925
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy and breast cancer.
    N Z Med J; 1976 Jun; 83(565):409-10. PubMed ID: 1067486
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
    Heuson JC; Paridaens R
    Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
    [No Abstract]   [Full Text] [Related]  

  • 19. Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinoma.
    Smith IE; Coombes RC; Evans BD; Ford HT; Gazet JC; Gordon C; McKinna JA; Powles TJ
    Eur J Cancer (1965); 1980; Suppl 1():271-3. PubMed ID: 7032939
    [No Abstract]   [Full Text] [Related]  

  • 20. Docetaxel: new preparation. No first-line use in metastatic breast cancer.
    Prescrire Int; 2001 Dec; 10(56):178-9. PubMed ID: 11824441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.